Driehaus Capital Management’s Integra LifeSciences IART Stock Holding History

Driehaus Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,122	Closed	-$667K	–	458
2018 Q3	$667K	Sell	10,122 -22,662	-69%	-$1.41M	0.02%	383
2018 Q2	$2.11M	Buy	+32,784	New	+$2.03M	0.07%	269
2017 Q3	–	Sell	-32,329	Closed	-$1.76M	–	528
2017 Q2	$1.76M	Buy	32,329 +5,432	+20%	+$259K	0.06%	277
2017 Q1	$1.13M	Buy	+26,897	New	+$1.15M	0.04%	344

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Driehaus Capital Management's IART Position: Q4 2018 in Review

Driehaus Capital Management sold out of Integra LifeSciences (IART) in Q4 2018, closing a stake of 10,122 shares — an estimated $667K sold.

Driehaus Capital Management first reported a position in IART in Q1 2017 and held it in 4 quarters. The position peaked at $2.11M in Q2 2018. 248 funds tracked by Wall St. Rank hold IART as of Q4 2018.

Driehaus Capital Management reported no remaining Integra LifeSciences position as of Q4 2018 after selling out during the quarter.
Driehaus Capital Management sold 10,122 Integra LifeSciences shares in Q4 2018, an estimated $667K.
Driehaus Capital Management first reported a position in Integra LifeSciences in Q1 2017 and held it in 4 quarters.
Driehaus Capital Management's Integra LifeSciences position peaked at $2.11M in Q2 2018.
248 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2018.

Based on Driehaus Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.